TradingKey

Citigroup’s Q3 2026 earnings call: revenue rose 8% to $23.8 billion, RoTCE reached 11.5%, and management raised its full-year return outlook.

• BioNTech shares fell after BNT113 failed its progression-free survival endpoint. • Executive insider share sales under pre-arranged trading plans occurred recently. • BioNTech reports an annual revenue of $3.33B and net loss.

• PBF Energy surged due to widening crack spreads and diesel product tightness. • UBS and Mizuho raised price targets following restored Martinez refinery production capacity. • Annual revenue reached $29.33B, alongside a net loss of $158.60M.

• Wells Fargo reported third-quarter earnings per share that exceeded consensus expectations. • Quarterly revenue missed Wall Street estimates due to operational softness in investment banking. • Management maintained its full-year net interest income guidance without upward revision.

• Banco Santander successfully completed the acquisition of Webster Financial Corporation. • Webster Financial shares were deregistered and trading on the NYSE ceased. • Shareholders receive merger consideration through a defined cash and stock structure.

• Canadian Natural Resources reported an annual revenue of $28.35B and net profit of $7.91B. • The MACD value of 0.732 indicates a buy signal for the stock. • Multiple analysts rated the company as Hold with an average price target of $71.26.

As the US earnings season approaches, Anthropic plans to disclose its third-quarter financial results on October 14. US stocks edged lower today, with AI hardware stocks recovering from early losses. At the close, the Dow Jones Industrial Average fell 0.35% to 51,670.10; the Nasdaq Composite Index fell 0.15% to 27,204.38; and the S&P 500 Index slipped 0.02% to 7,805.45.

Wells Fargo Q3 2026 earnings call: EPS rose 30% to $1.87, ROTCE reached 16.3%, and management maintained its $50 billion NII outlook.

UnitedHealth Group Q3 2026 earnings call: revenue reached $113 billion, adjusted EPS rose to $4.69, and 2026 EPS guidance increased to at least $20.50.

JPMorgan Chase Q3 2026 earnings call: net income reached $15.3 billion as revenue rose 8%, with management outlining Q4 NII and expense guidance.

FB Financial’s Q3 2026 earnings call covered $1.20 EPS, 9.7% annualized loan growth, 3.83% net interest margin and updated growth and expense guidance.

Johnson & Johnson Q3 2026 sales rose 6% to $25.4 billion as Innovative Medicine grew 7.9%. JNJ raised and narrowed its full-year sales guidance.

Domino’s Pizza Q3 2026 earnings call: operating income rose 8.5%, U.S. comps gained 0.3%, while management lowered store growth and international guidance.

Goldman Sachs Q3 2026 earnings call: revenue reached $18.7 billion as equities, investment banking and asset management drove strong returns.

The memory sector recently declined on news that China's ChangXin Memory Technologies (CXMT) is advancing its next-generation DRAM architecture. However, CXMT is focusing on DRAM products such as server DDR5, whereas SanDisk's (SNDK) core business consists of NAND flash memory, enterprise SSDs, and data center storage solutions, meaning no direct product substitution exists between the two.

• Summit Therapeutics shares declined due to profit-taking following a recent corporate rally. • Investors are reducing risk ahead of upcoming Phase III clinical data readouts. • Proposed common share count expansion raised potential future share dilution concerns.

• Phillips 66 benefits from elevated global crack spreads and resilient fuel demand. • Integrated operations and accelerated balance sheet deleveraging reinforce strong cash flows. • Analysts upgraded earnings estimates, while technical indicators show strong buy signals.

• Marathon Petroleum rose due to price target upgrades and expanding refining margins. • Tight global supply conditions kept product prices strong relative to raw crude. • Disciplined capital management through buybacks and dividends continues attracting institutional capital.

• ASML faced selling pressure as investors de-risked ahead of Q3 earnings. • Semiconductor sector headwinds and Chinese chipmaker progress created capital allocation caution. • Premium valuation and macro uncertainties contributed to ongoing stock market volatility.

• Flex shares declined due to spin-off liabilities and Axiom Solutions financing concerns. • Investors worry about convertible preferred stock dividend obligations and buyback guarantees. • Profit-taking and high sector valuations further amplified the recent stock pullback.